Vancouver, B.C. and Boston, MA, December 20, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the...
Read More
Vancouver, B.C. and Boston, MA, December 18, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce the results...
Read More
Vancouver, B.C. and Boston, MA, November 28, 2018 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) wishes to make the following...
Read More
The use of blue light flexible cystoscopy with hexaminolevulinate & the diagnosis of bladder cancer.
Clinton TN, Lotan Y.
Future Oncol. 2018 Nov;14(27):2805-2810. doi: 10.2217/fon-2018-0328. Epub 2018 Jun 21.
PMID: 29925279 Review.
https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fpubmed.ncbi.nlm.nih.gov%2f29925279%2f&c=E,1,whPk_v4XrIxILe80ufZnSni-pAKcei3RQJoFdTGjQgFsNsLZFQraNjCLoGd3p7-TTII0CbCh8BGxUyYsyKttofqyjGCc9Ve2ewBxd_DuOmQ_gshzKmE66G2M&typo=1
Vancouver, B.C. and Boston, MA, October 31, 2018 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced today that it has received proceeds...
Read More
Vancouver, B.C. and Boston, MA, October 2, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced that Steven Chan has resigned...
Read More
Vancouver, B.C. and Boston, MA, August 14, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the...
Read More
Vancouver, B.C. and Boston, MA, July 25, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that, pursuant to the Company’s Stock...
Read More
Vancouver, B.C. and Boston, MA, July, 17, 2018 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced todayfavorable results in the 10-subject investigator-sponsored...
Read More
Vancouver, BC and Boston, MA, June 27, 2018 – Imagin Medical (CSE: IME) (OTCPINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce that its...
Read More
